ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
5.33
+0.08 (1.52%)
Dec 4, 2025, 4:00 PM EST - Market closed
ImmuCell Market Cap
ImmuCell has a market cap or net worth of $48.21 million as of December 5, 2025. Its market cap has increased by 52.83% in one year.
Market Cap
48.21M
Enterprise Value
56.85M
1-Year Change
52.83%
Ranking
Category
Stock Price
$5.33
Market Cap Chart
Since May 1, 1992, ImmuCell's market cap has increased from $1.99M to $48.21M, an increase of 2,320.40%. That is a compound annual growth rate of 9.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 47.13M | 2.69% |
| Dec 31, 2024 | 45.89M | 16.33% |
| Dec 29, 2023 | 39.45M | -16.51% |
| Dec 30, 2022 | 47.26M | -23.70% |
| Dec 31, 2021 | 61.94M | 44.32% |
| Dec 31, 2020 | 42.92M | 15.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |